More Big Tech Results… And Dissecting The Latest Pharma Moves 10/30/25
CNBC's "Fast Money"
00:00
Novo Nordisk's Unsolicited Bid for MetSera
Panel examines Novo's surprising offer for MetSera, legal complexities, strategic motives, and potential desperation in pharma M&A.
Play episode from 40:32
Transcript
